This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DENNISON YOUNG, M.D.; MANUEL RODSTEIN, M.D.

AMA Arch Intern Med. 1952;90(1):64-78.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

STUDIES on cortisone and corticotropin (ACTH) treatment of rheumatic fever have been primarily limited to acute cases of relatively short duration. The beneficial effects first reported by Hench and his associates¹ have been confirmed by subsequent investigators,² although more recent reports³ have served to temper some of the previous enthusiasm. The number of patients with chronic active rheumatic fever so treated is relatively few, and, because of this, observations on, and end-results obtained in, a group of patients of this type treated with large and prolonged dosages of cortisone or corticotropin should be of interest.

MATERIAL

Between June, 1950, and August, 1951, eight children, ranging from 8 to 16 years of age, and suffering from prolonged chronic active rheumatic fever, were treated with cortisone or corticotropin and subsequently followed for 2 to 13 months after cessation of therapy. Six children had been observed by us on a Home Care Rheumatic . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Medical Division (Dr. Louis Leiter, Chief), Montefiore Hospital.

Footnotes
This study was supported in part by a grant from the New York Heart Association to the Home Care Rheumatic Fever Program.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?